U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C24H22Cl2N4O5
Molecular Weight 517.361
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)-2,3-PIPERAZINEDIONE, CIS-

SMILES

ClC1=CC(Cl)=C(C=C1)[C@@]3(CN2C=CN=C2)OC[C@H](COC4=CC=C(C=C4)N5CCNC(=O)C5=O)O3

InChI

InChIKey=HQSHCFXABCJJOF-CYFREDJKSA-N
InChI=1S/C24H22Cl2N4O5/c25-16-1-6-20(21(26)11-16)24(14-29-9-7-27-15-29)34-13-19(35-24)12-33-18-4-2-17(3-5-18)30-10-8-28-22(31)23(30)32/h1-7,9,11,15,19H,8,10,12-14H2,(H,28,31)/t19-,24-/m0/s1

HIDE SMILES / InChI

Molecular Formula C24H22Cl2N4O5
Molecular Weight 517.361
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Tue Apr 01 20:56:12 GMT 2025
Edited
by admin
on Tue Apr 01 20:56:12 GMT 2025
Record UNII
ZF74VO947S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2,3-PIPERAZINEDIONE, 1-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)-, CIS-
Preferred Name English
1-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)-2,3-PIPERAZINEDIONE, CIS-
Systematic Name English
Code System Code Type Description
FDA UNII
ZF74VO947S
Created by admin on Tue Apr 01 20:56:12 GMT 2025 , Edited by admin on Tue Apr 01 20:56:12 GMT 2025
PRIMARY
PUBCHEM
101671865
Created by admin on Tue Apr 01 20:56:12 GMT 2025 , Edited by admin on Tue Apr 01 20:56:12 GMT 2025
PRIMARY
CAS
159898-58-5
Created by admin on Tue Apr 01 20:56:12 GMT 2025 , Edited by admin on Tue Apr 01 20:56:12 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE INACTIVE
Evidence that CYP3A4 plays a significant role in metabolism of ketoconazole is that co-administration of CYP3A4 inducers, such as phenytoin, carbamazepine, and rifampin, can cause as much as a 50% reduction in levels of ketoconazole.
MAY BE CLINICALLY SIGNIFICANT